Sudeep Pharma IPO Details
| IPO Open Date | November 21, 2025 |
| IPO Close Date | November 25, 2025 |
| Face Value | ₹1 Per Equity Share |
| IPO Price Band | ₹563 to ₹593 Per Share |
| Issue Size | Approx ₹895 Crores |
| Fresh Issue | Approx ₹95.00 Crores |
| Offer for Sale: | Approx 1,34,90,726 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Sudeep Pharma IPO Review & Key Points
- Review:
Sudeep Pharma IPO Market Lot
The Sudeep Pharma IPO minimum market lot is 25 shares with ₹14,825 application amount. The retail investors can apply up-to 13 lots with 325 shares of ₹1,92,725 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 25 | ₹14,825 |
| Retail Maximum | 13 | 325 | ₹1,92,725 |
| S-HNI Minimum | 14 | 350 | ₹2,07,550 |
| S-HNI Maximum | 67 | 1,675 | ₹9,93,275 |
| B-HNI Minimum | 68 | 1,700 | ₹10,08,100 |
IPO Reservation
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 75,46,376 Shares | 50% |
| NII Shares Offered | 22,63,912 Shares | 15% |
| Retail Shares Offered | 52,82,462 Shares | 35% |
Sudeep Pharma IPO Anchor Investors
| Anchor Bidding Date | November 20, 2025 |
| Anchor Investors List | |
| Shares Offered | 45,27,823 Shares |
| Anchor Size | 268.50 Cr. |
| lock-in period end date 50% shares (30 Days) | December 26, 2025 |
| lock-in period end date 50% shares (90 Days) | February 24, 2026 |
Sudeep Pharma IPO Dates
The Sudeep Pharma IPO date is November 21 and the close date is November 25 The Sudeep Pharma IPO allotment will be finalized on November 26 and the IPO listing on November 28.
| IPO Open Date: | November 21, 2025 |
| IPO Close Date: | November 25, 2025 |
| Basis of Allotment: | November 26, 2025 |
| Refunds: | November 27, 2025 |
| Credit to Demat Account: | November 27, 2025 |
| IPO Listing Date: | November 28, 2025 |
| IPO Bidding Cut-off Time: | November 25, 2025 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani Huf, Riva Resources Private Limited And Bhayani Family Trust.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 11,13,46,602 | 89.37% |
| Promoter Holding Post Issue | 11,29,48,626 | 76.15% |
Objects of the Issue & Utilisation of proceeds
| Purpose | Crores |
| Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I | 75.81 |
| General corporate purposes | – |
About Sudeep Pharma IPO
Sudeep Pharma Limited, founded in 1989, is one of the leading manufacturers of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries. They aim to support the global healthcare ecosystem by serving their product to over 100 countries and supplying more than 200 products. To support innovation in their work, they use their own in-house technologies for encapsulation, spray drying, granulation, trituration, liposomal preparations, and mixing.
Their business is basically structured into 2 verticals: 1) Pharmaceutical, food, and nutrition, which includes key mineral salts such as calcium, zinc, iron, potassium, magnesium, sodium, and copper, and 2) Specialty Ingredients includes micronutrient premixes, encapsulated ingredients, granulated minerals, and triturated blends. Moreover, Sudeep Pharma runs six manufacturing facilities with a total production capacity of 50,000 MT.
Sudeep Pharma IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2022 | ₹351.00 | ₹282.46 | ₹49.80 | ₹345.00 |
| 2023 | ₹438.26 | ₹352.28 | ₹62.32 | ₹420.11 |
| 2024 | ₹465.38 | ₹290.56 | ₹133.15 | ₹513.87 |
| 2025 | ₹511.33 | ₹328.48 | ₹138.69 | ₹717.17 |
| June 2025 | ₹130.08 | ₹86.00 | ₹31.27 | ₹922.26 |
Sudeep Pharma IPO Valuation – FY2025
Check Sudeep Pharma IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 28.13% |
| ROCE: | 29.82% |
| EBITDA Margin: | 39.70% |
| PAT Margin: | 27.63% |
| Debt to equity ratio: | 0.20 |
| Earning Per Share (EPS): | ₹12.78 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 27.88% |
| Net Asset Value (NAV): | ₹45.86 |
Peer Group Comparison
- There are no peer group companies listed in India.
IPO Lead Managers aka Merchant Bankers
- ICICI Securities Ltd.
- IIFL Capital Services Ltd.
Company Address
Sudeep Pharma Ltd.
129/1/A,
GIDC Estate,
Nandesari,
Vadodara, Gujarat, 391340
Phone: +91 265 284 0656
Email: [email protected]
Website: https://www.sudeeppharma.com/
IPO Registrar
MUFG Intime India Pvt. Ltd.
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Sudeep Pharma IPO FAQs
What is Sudeep Pharma IPO?
When Sudeep Pharma IPO will open for subscription?
What is Sudeep Pharma IPO Investors Portion?
How to Apply the Sudeep Pharma IPO?
What is Sudeep Pharma IPO Issue Size?
What is Sudeep Pharma IPO Price Band?
What is Sudeep Pharma IPO Lot Size?
What is the Sudeep Pharma IPO Allotment Date?
What is the Sudeep Pharma IPO Listing Date?
Note: The Sudeep Pharma IPO price band and date are officially announced. The (Sudeep Pharma IPO grey market premium) will be added to the IPO GMP page as it will start).
